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A permethylated-reduced hexaglycosylceramide in a complex glycolipid mixture isolated 
from a unique human tissue has been identified by using tandem mass spectrometry 
(MS/MS). The mass spectrum of this glycolipid mixture, obtained by using in-beam 
electron ionization, is very complex, and fragment ions derived from the hexaglycosylce- 
ramide cannot be distinguished from other ions. Tandem mass spectrometry using a 
four-sector mass spectrometer gave the mass spectrum of the immonium ion of the 
permethylated-reduced hexaglycosylceramide (m /z 1645.8), which is characteristic of its 
structure. Comparison of this MS/MS spectrum with those of two similarly derivatized 
blood group hexaglycosylceramide isomers permitted identification of the unknown glyco- 
lipid structure. (J Am Sot Mass Spectrom 1992, 3, 353-359) 
C 
elI membrane glycolipids occur in biological 
systems as complex mixtures whose composi- 
tion is specific to species, individuals, tissues, 
and cells [l, 21. Their particular biomedical impor- 
tance is due to their activity as determinants within 
the major blood group systems (ABO, Lewis, X, I, 
and l?) [l, 31. Their biologicai properties as transplan- 
tation antigens, tumor-associated antigens, and recep- 
tors for microbes [l-5] make their structural character- 
ization important. The complex nature of glycolipid 
fractions necessitates the use of analytical techniques 
that combine high sensitivity and structural specificity 
with the ability to analyze components from a mix- 
ture. 
Recently, a number of chromatographic techniques 
have been used in conjunction with mass spectrome- 
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try to tackle such problems, including gas chroma- 
tography mass spectrometry (GC/MS) [6], liquid 
chromatography mass spectrometry (LC/MS) [7], 
thin-layer chromatography mass spectrometry 
(TLC/MS) [8, 91, and supercritical fluid chromatogra- 
phy mass spectrometry (SFC/MS) [lo]. The introduc- 
tion of the permethylated and permethylated-reduced 
derivatives of glycolipids for electron ionization 
(EI/MS) analysis of pure glycolipids [ll-131 con- 
tributed significantly to the structural analysis of small 
amounts of glycolipids. This was further developed 
into the analysis of sample glycolipid mixtures [13-151 
by taking advantage of the difference in the tempera- 
tures at which glycolipids of different molecular 
weights evaporate. In this experiment, the cuvette 
containing the glycolipid sample is heated while spec- 
tra are recorded continuously as the glycolipid species 
evaporate. By placing the cuvette close to the ionizing 
electron beam, it has been possible to obtain spectra 
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from glycolipids with up to 12 sugars as pure com- 
pounds [16] and with up to 11 sugars in a mixture 
u51. 
Underivatized glycolipids have also been studied 
by “soft” ionization techniques, especially fast atom 
bombardment (FAB/MS) [12-N]. However, FAB/MS 
has serious disadvantages when applied to mixtures 
of glycosphingolipids (CSLs), which exhibit hetero- 
geneity in both saccharide and ceramide moieties. 
First, because all components are ionized more or less 
simultaneously, FAB /MS does not give the advantage 
of partial separation by distillation. The inherent dif- 
ficulty with FAB/MS of glycolipids in distinguishing 
between molecule ions and fragment ions is thus not 
facilitated and this becomes increasingly difficult with 
increasing molecular size. It may be partially over- 
come by the use of FAB ionization in conjunction with 
tandem mass spectrometry (FAB/MS/MS) [17], but 
this approach may not always be feasible. Another 
disadvantage of FAB ionization applied to mixtures is 
the effect of competitive ionization [20], whereby one 
or more components dominate the spectrum so that 
other possibly major components appear as only weak 
peaks in the spectrum, which may be overlooked 
on interpretation. However, a major advantage of 
FAB/MS is that prior derivatization of the glycolipids 
is not required. 
Another approach to glycolipid analysis was re- 
cently described [21] which employed an electrospray 
ionization (ESI) source combined with a triple- 
quadrupole mass spectrometer. The doubly charged 
molecular ions of two gangliosides (M, = 2000) in 
positive ion mode showed considerable heterogene- 
ity, covering - 80 mass-to-charge units. Signifi- 
cantly, in negative ion mode the spectrum around the 
doubly charged molecular ion region was greatly sim- 
plihed. The combination of ES1 with high perfor- 
mance MS/MS may prove to be a powerful tool for 
glycolipid analysis in the future. 
A major advance in the study of large biomolecules 
has been the development of “high performance” 
MS/MS by combining two high resolution double- 
focusing mass spectrometers [22-241. Unit mass par- 
ent ion resolution is essential for collision-induced 
dissociation experiments on samples of biological ori- 
gin because these often contain variants of similar 
mass. In addition, isotopic contributions become in- 
creasingly significant at higher mass and these com- 
plicate the daughter ion spectrum. Daughter ion mass 
accuracies of better than f 0.3 u are required to unam- 
biguously assign peaks. The necessity for high energy 
collisions has been widely discussed [25]. These crite- 
ria, which are essential for structural analysis, are all 
achieved by current commercial four-sector instru- 
ments that have yielded MS/MS spectra on molecules 
of up to - 2500 u. 
In a recent publication [15], we have highlighted 
the potential use of a four-sector instrument to im- 
prove the level of structural information obtainable 
from the high mass compounds using the distillation- 
EI method described above. It was found that as the 
complexity of the mixture increases, so the interpreta- 
tion of the resulting spectra becomes increasingly am- 
biguous, for three main reasons. First, in a complex 
mixture immonium ions from a given GSL are not 
easily discriminated from fragment ions (sequence 
ions) from other GSLs. Second, the origins of frag- 
ment ions from different GSLs are not easily estab- 
lished. Third, the number of possible isomeric struc- 
tures giving rise to isobaric immonium ions increases, 
especially with increasing mass. For a given fatty 
acid-containing immonium ion, these isomeric struc- 
tures can arise due to different linkages within the 
carbohydrate chain, as well as different carbohydrate 
sequences. 
The present work describes the analysis of two 
blood group hexaglycosylceramide isomers by 
EI/MS/MS and the application of this technique to 
the successful identification of a hexaglycosylceramide 
in a glycolipid mixture isolated from a unique human 
tissue sample. 
Experimental 
Sample Preparation 
Reference glycolipids. Blood group Leb and B hexagly- 
cosylceramides were isolated from human small intes- 
tine and pancreas, respectively [26]. Their structures 
were established by mass spectrometry, proton nu- 
clear magnetic resonance spectroscopy and degrada- 
tion analysis [26]. The EI mass spectra of the permeth- 
ylated and the permethylated-reduced blood group B 
compound are described in Breimer [26], and the 
spectra of the corresponding Leb glycolipid isolated 
from human plasma in Falk et al. [27]. 
Human liver glycolipid fraction. The liver from a blood 
group A,Le(a - b + ) human individual was trans- 
planted into a blood group 0 recipient. Because of 
incompatible organ size, part of the liver was resected 
and analyzed. A total nonacid glycolipid fraction was 
prepared as described [28], and by high performance 
liquid chromatography a blood group glycolipid frac- 
tion migrating in the 6/7 sugar region on the thin-layer 
plate was isolated. A detailed structural investigation 
of the liver glycolipids (to be published elsewhere) 
revealed for the sample analyzed in this article a 
blood group A difucosyl heptaglycosylceramide as 
major component, a Leb hexaglycosylceramide, and 
traces of a blood group A monofucosylhexaglycosyl- 
ceramide. 
Derivatizations. The reference glycolipids were per- 
methylated by using the method of Hakomori [29] 
and the liver sample by the method of Ciucanu and 
Kerek [30] and Larson et al. [31]. The permethylated 
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glycolipids were reduced by LiAIH, in diethyl ether 
as described [32]. 
Mass Spectrometry 
The mass spectrum shown in Figure 1 was recorded 
at the University of Giiteborg by using a VG Instru- 
ments Analytical ZAB-2F spectrometer (Manchester, 
UK), as described previously [13-151. 
All other spectra shown were obtained by using a 
Kratos Analytical Concept II HH four-sector mass 
spectrometer (Manchester, UK) at the University of 
Warwick. In this method l-10 .ug of the permeth- 
ylated-reduced GSL samples were loaded onto a ce- 
ramic probe-tip having adjustable length and orienta- 
tion. The tip was placed l-2 mm from the electron 
beam and heated only via contact with the source 
block. The source block temperature was manually 
ramped between 200 and 320 “C until appropriate 
conditions were found. Under these conditions the 
reference glycolipids gave signals lasting up to 5 min. 
The human liver fraction gave less stable signals last- 
ing only - 2 min. The accelerating voltage was 8 kV, 
the electron energy 100 eV, and the trap stabilization 
current 500 PA. The instrument was operated with an 
MS-I resolution of 2000, and MS-II resolution of 1000. 
AU tandem mass spectra were obtained with a colli- 
sion energy of 6 keV and a 60% beam attenuation 
using He collision gas. A scan speed of 10 s/decade 
was used for the mass spectra shown in Figure 1. All 
tandem mass spectra were recorded as “raw data,” 
using a scan speed of 30 s/decade and averaging 
three to ftve scans. 
could correspond to either a structure containing a 
hexose plus non-hydroxy fatty acid, OT a structure 
containing a deoxyhexose plus hydroxy fatty acid. 
The two immonium ions shown in Scheme I differ in 
exactly this way, and so give rise to isobaric immo- 
mum ions at m/z 1645.8. In the case of the purified 
glycolipids, the mass spectra show series of sequence 
ions which readily distinguish the two structures (Fig- 
ure 2 and Scheme l). For example, in the blood group 
B GSL specirum, a fragment ion appears at m/z 
828.3, which is due to the tetrasaccharide Hex-O- 
Hex(-0-Fuc)-0-HexNAc. The corresponding ion in the 
blood group Leb GSL spectrum appears at m/z 798.3, 
owing to the tetrasaccharide fragment Hex(-O-Fuc)- 
HexNAc-(0-Fuc), i.e., with one hexose replaced by 
deoxyhexose (fucose) resulting in a shift of 30 u. 
However, in a mixture the glycolipids give rise to a 
vastly more complex mass spectrum, as illustrated by 
the spectrum of the human liver glycolipid mixture 
(Figure 1) in which any sequence ions are indistin- 
guishable from, or burled beneath, ions arising from 
other components of the mixtore (Samuelsson et al., 
to be published). Thus, the immonium ion at m /z 
1645 could be assigned to either a blood group B or a 
blood group Leb hexaglycosylceramide structure. 
In contrast to this situation, the tandem mass spec- 
trum contains only ions which are fragments of a 
preselected parent ion, provided that the mass resolu- 
tion of MS-I is sufficient to resolve the parent ion from 
its nearest neighbor. Therefore, it was hoped that by 
recording the tandem mass spectra of the isobaric 
immonium ions at m/z 1645.8 of the GSLs of blood 
groups B and Leb, it would be possible unambigu- 
ously to identify their sequence. This technique could 
Results and Discussion then be applied to complix glycolipid mixhi& where 
sequence ions are often difficult to identify. Figure 3a 
The mass spectra of the permethylated-reduced blood 
group B and Leb hexaglycosylceramides are shown in 
and b shows the resulting tandem mass spectra, 
recorded using an MS1 resolution of 2000. The tan- 
Figure 2. As described previously [11], such spectra dem mass spectra of the immonium ions of the two 
are dominated by immonium ions which arise by loss hexaglycosylceramides clearly identify the structures 
of the alkyl group associated with the long chain base as being those of the blood group B and Leb com- 
with retention of the alkyl group from the acyl moi- pounds. Structurally significant ions at m/z 157, 189, 
ety. These immonium ions are evident - m/r 424, 798, 1002, 1176, 1206, 1485, 1600, and 1613 are 
1600-1650 (Figure 2a and b). The series of immonium present in the spectrum of the Leb compound (Figure 
ions is due to variation in the chain length and hy- 3b). In the tandem mass spectrum of the immonium 
droxylation of the fatty acid. Of particular interest are ion of the blood group B compound (Figure 3a), peaks 
the immonium ions at m/z 1645.8, whose structures are seen at mfz 394, 596, 828, 1048, 1206, and 1455 
are shown in Scheme I. This example illustrates how, corresponding to the sequence shown in Scheme Ia. 
as the molecular mass of the glycolipid increases, the An ion of m/z 1206 is also present in the Leb spec- 
interpretation of the resulting spectra becomes in- trum, and is due to the loss of the hexasaccharide 
creasingly ambiguous. Thus, with increasing sugar- (Scheme lb). The equivalent loss for the blood group 
chain length the number of possible structures for B immonium ion results in a fragment ion of m/z 
each series of immonium ions which retain the alkyl 1236 (30 mass units higher due to one deoxyhexose 
group from the’acyl moiety (fatty acid), increases. For being replaced by hexose). The fragment ion at m/z 
example, an exchange of a hexose for a deoxyhexose 1206 for the blood group B immonium ion may be due 
residue means loss of 30 mass units, which is the to loss of both the terminal hexose and fucose (Scheme 
same as the loss obtained by substitution of a hydroxy Ia). This idea is supported by the presence of weaker 
fatty acid by a non-hydroxy acid in the lipophilic part ions at m/z 1222 and 1236, representing retention of 
of the GSL [ll, l.21. Thus, a given immonium ion the glycosidic linkages. 
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Figure 1. “In beam” EI mass spectra of the permethylated- 
reduced hexaglycosylceramides of (a) blood group 8, (b) Wood 
group Leb. 
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The EI/MS/MS technique was then applied to a 
mixture of glycolipids isolated from a liver of a blood 
group A, Le(a - b + ) human individua1. In this way 
it was hoped that sequence data could be obtained for 
a single fatty acid-containing immonium ion present 
in the complex spectrum shown in Figure 2. The 
resulting tandem mass spectrum of m/z 1645.8 (Fig- 
ure 3c) shows fragment ions at m/z 157, 189, 424, 
798, 1002, 1176, 1206, 1485, 1600, and 1613, corre- 
sponding to the sequence of the Leb-6 compound, 
(compare Figure 3b). This clearly establishes the pres- 
ence of the Leb-6 compound in the liver glycolipid 
mixture, despite the rather poor signal-to-noise level 
shown in Figure 3c. The latter is in part due to the 
transient nature of the parent ion signal recorded 
using the distillation-E1 technique on such a mixture. 
Conclusions 
This work illustrates the utility of four-sector mass 
spectrometry in the direct structural analysis of 
molecules in the low kilodalton range from highly 
complex mixtures of biological origin. This was 
achieved without the use of on-line chromatography. 
The major drawback of the method lies in the 
difficulty in achieving sufficiently intense parent ions 
required to obtain acceptable tandem mass spectra, 
from trace amounts of material. For example, the 
tandem mass spectrum shown in Figure 3b results 
from a parent ion signal in the range 300-800 mV at a 
gain of 106, and lasting long enough for one to two 
scans. The disappointing signal-to-noise level seen in 
the tandem mass spectrum obtained from the liver 
extract illustrates the need for greater sensitivity. 
However, it may be that a 1-lo-pg sample represents 
a mixture of several compounds and one immonium 
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Scheme I. Immonium ions of the permethylated-reduced hexaglycosylceramides at m/z 1645.8 
for (a) blood group 8, (b) blood group L.eb, showing modes of fragmentation seen in MS and 
MS/MS spectra. 
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Figure 2. “In beam” El mass spectrum of perrnethylated-reduced human liver glycolipid fraction 
obtained by using a VG Instruments ZAB-2F. The sample was introduced “in beam” at 300 ‘C and 
the source temperature was ramped at 6 “C per minute. Mass spectra were recorded continuously. 
The reproduced spectrum is 1.5 out of 22. Trap current was 200 PA and electron energy 52 eV. 
Simplified formulas are shown above the spectrum for interpretation. 
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ion represents one species out of several (16-26 car- 
bon fatty acids, hydroxy, or non-hydroxy). In such a 
perspective the sensitivity is reasonable. The most 
promising development allowing such an increase in 
sensitivity is the recent use [33, 341 of the simultane- 
ous detection of ions over a given mass range using 
electrooptical multichannel array detectors. Such de- 
tection system can result in up to one hundredfold 
increase in sensitivity [33] over conventional point 
detectors, such as the electron multiplier used in the 
present work. It is hoped for the future that by com- 
bining the benefits of array detection with some 
refinements to the ionization technique, the identih- 
cation of GSLs by MS/MS could become a well-estab- 
lished procedure. This would have major benefits in 
the area of organ transplantation, where donor organ 
blood group phenotyping on small tissue samples 
might be a prerequisite for carbohydrate-based blood 
group compatibility between donor organ and recipi- 
ent, thus resulting in a good graft survival. 
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